NL7019097A - - Google Patents

Info

Publication number
NL7019097A
NL7019097A NL7019097A NL7019097A NL7019097A NL 7019097 A NL7019097 A NL 7019097A NL 7019097 A NL7019097 A NL 7019097A NL 7019097 A NL7019097 A NL 7019097A NL 7019097 A NL7019097 A NL 7019097A
Authority
NL
Netherlands
Application number
NL7019097A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7019097A publication Critical patent/NL7019097A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7019097A 1969-12-31 1970-12-31 NL7019097A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6945776A FR2073293B1 (fr) 1969-12-31 1969-12-31

Publications (1)

Publication Number Publication Date
NL7019097A true NL7019097A (fr) 1971-07-02

Family

ID=9045518

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7019097A NL7019097A (fr) 1969-12-31 1970-12-31

Country Status (11)

Country Link
JP (1) JPS4940922B1 (fr)
AT (1) AT301749B (fr)
BE (1) BE760727A (fr)
CA (1) CA956573A (fr)
CH (1) CH533988A (fr)
DE (1) DE2064296C2 (fr)
DK (1) DK128054B (fr)
FR (1) FR2073293B1 (fr)
GB (1) GB1326928A (fr)
LU (1) LU62332A1 (fr)
NL (1) NL7019097A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027429A2 (fr) * 1979-10-11 1981-04-22 Bonifacio Gaetana Procédé d'extraction d'antidotes de tumeurs (oncoclasine) à partir d'excréments de chêvres

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5330639U (fr) * 1976-08-20 1978-03-16
JPS5925332A (ja) * 1982-08-04 1984-02-09 Mochida Pharmaceut Co Ltd 抗腫瘍性糖蛋白質の製法
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
GB8614733D0 (en) * 1986-06-17 1986-07-23 Lefesvre A Aids treatment

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027429A2 (fr) * 1979-10-11 1981-04-22 Bonifacio Gaetana Procédé d'extraction d'antidotes de tumeurs (oncoclasine) à partir d'excréments de chêvres
EP0027429A3 (en) * 1979-10-11 1982-05-12 Liborio Dr. Bonifacio Tumor antidote (oncoclasine) for the cure of tumors, and process for its extraction

Also Published As

Publication number Publication date
CA956573A (en) 1974-10-22
LU62332A1 (fr) 1971-05-27
BE760727A (fr) 1971-05-27
AT301749B (de) 1972-09-11
FR2073293A1 (fr) 1971-10-01
CH533988A (fr) 1973-02-28
FR2073293B1 (fr) 1973-01-12
GB1326928A (en) 1973-08-15
DE2064296A1 (de) 1971-07-15
JPS4940922B1 (fr) 1974-11-06
DK128054B (da) 1974-02-25
DE2064296C2 (de) 1984-10-25

Similar Documents

Publication Publication Date Title
AU465452B2 (fr)
AU450150B2 (fr)
AU442375B2 (fr)
AU470301B1 (fr)
AU5113869A (fr)
CS149424B2 (fr)
AU442380B2 (fr)
AU442463B2 (fr)
AU442538B2 (fr)
AU442554B2 (fr)
AU442357B2 (fr)
AU470661B1 (fr)
AU442322B2 (fr)
CS148422B1 (fr)
CS149291B1 (fr)
AU4949169A (fr)
AU5397469A (fr)
AU5228269A (fr)
AU5133369A (fr)
AU5077469A (fr)
AU5109569A (fr)
AU4540468A (fr)
AU469091A (fr)
AU4953367A (fr)
BG16994A3 (fr)